Fig. 1From: Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerExamples of ESRP1 and ESRP2 cytoplasmic and nuclear immunostaining in prostate cancer. Left side: Immunostaining on the whole TMA spot. Right side: Selected parts of a TMA spotBack to article page